Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Dual-gene regulation of NGF overexpression and P75NTR knockdown enhances BMSC osteogenesis by suppressing pyroptosis.

Created on 23 Aug 2026

Authors

Ying Ji, Zheng Lv, Ye Wang, Yongkang Mao, Honghu Lin, Jianjia Huang, Hoan Nguyen Quoc, Chaoyong Bei

Published in

iScience. Volume 29. Issue 8. Pages 116979. Aug 21, 2026. Epub Aug 12, 2026.

Abstract

Bone defects present a major clinical challenge in regenerative medicine, where bone marrow mesenchymal stem cells (BMSCs) are widely used but often show limited osteogenic efficacy. In this study, we developed an engineered tissue strategy combining lentivirus-mediated dual-gene regulation and an allogeneic bone scaffold to enhance bone regeneration. BMSCs were modified to overexpress nerve growth factor (NGF) and knock down the p75 neurotrophin receptor (P75NTR), and their effects on osteogenesis and pyroptosis were evaluated in vitro and in a rat femoral condyle defect model. The dual-gene modification suppressed NF-κB nuclear translocation and reduced pyroptosis-related protein expression, while significantly enhancing osteogenic differentiation of BMSCs. In vivo, scaffold-assisted delivery of engineered BMSCs promoted new bone formation and improved structural regeneration in critical-sized defects. These findings demonstrate that coordinated regulation of NGF and P75NTR signaling within a biomaterial-based system can enhance stem cell-mediated bone repair and improve functional bone regeneration outcomes.

PMID:
42633095
Bibliographic data and abstract were imported from PubMed on 23 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement